Horizon Therapeutics PLC (HZNP)
115.69
0.00 (0.00%)
USD |
NASDAQ |
Sep 29, 16:00
115.67
-0.02
(-0.02%)
After-Hours: 20:00
Horizon Therapeutics Net Income (TTM): 438.00M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 438.00M |
| March 31, 2023 | 371.90M |
| December 31, 2022 | 521.48M |
| September 30, 2022 | 574.26M |
| June 30, 2022 | 764.96M |
| March 31, 2022 | 862.10M |
| December 31, 2021 | 534.49M |
| September 30, 2021 | 551.87M |
| June 30, 2021 | 518.16M |
| March 31, 2021 | 280.04M |
| December 31, 2020 | 389.80M |
| September 30, 2020 | 792.01M |
| June 30, 2020 | 517.40M |
| March 31, 2020 | 592.29M |
| December 31, 2019 | 573.02M |
| September 30, 2019 | 81.90M |
| June 30, 2019 | 97.04M |
| March 31, 2019 | 77.41M |
| December 31, 2018 | -38.38M |
| September 30, 2018 | -126.07M |
| June 30, 2018 | -223.42M |
| March 31, 2018 | -408.21M |
| December 31, 2017 | -350.12M |
| September 30, 2017 | -493.35M |
| June 30, 2017 | -435.25M |
| Date | Value |
|---|---|
| March 31, 2017 | -210.73M |
| December 31, 2016 | -165.56M |
| September 30, 2016 | -12.30M |
| June 30, 2016 | -3.151M |
| March 31, 2016 | 13.68M |
| December 31, 2015 | 39.53M |
| September 30, 2015 | -16.11M |
| June 30, 2015 | -17.32M |
| March 31, 2015 | -76.91M |
| December 31, 2014 | -263.60M |
| September 30, 2014 | -334.86M |
| June 30, 2014 | -342.41M |
| March 31, 2014 | -333.08M |
| December 31, 2013 | -149.00M |
| September 30, 2013 | -70.44M |
| June 30, 2013 | -81.90M |
| March 31, 2013 | -86.24M |
| December 31, 2012 | -87.79M |
| September 30, 2012 | -140.19M |
| June 30, 2012 | -140.47M |
| March 31, 2012 | -129.32M |
| December 31, 2011 | -113.27M |
| September 30, 2011 | -50.09M |
| June 30, 2011 | -45.35M |
| March 31, 2011 | -26.83M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-38.38M
Minimum
Dec 2018
862.10M
Maximum
Mar 2022
447.36M
Average
518.16M
Median
Jun 2021
Net Income (TTM) Benchmarks
| Amgen Inc | 7.979B |
| Pfizer Inc | 21.47B |
| Perrigo Co PLC | -67.70M |
| Jazz Pharmaceuticals PLC | -86.51M |
| Iterum Therapeutics PLC | -56.33M |